Cornell
Biotia Raises $8M in Series A Financing
The New York-based startup said the funding will be used to expand its technical capabilities, regulatory compliance, and marketing reach.
Eurofins Viracor Acquires Exclusive License to Cornell Cell-Free DNA Assay Technology
The company intends to use the technology to develop assays for monitoring tissue damage associated with COVID-19 infection and transplantation.
With bisulfite whole-genome sequencing of cfDNA from blood, researchers were able to monitor graft-versus-host disease, infection, graft failure, and disease relapse.
At-Home Coronavirus Tests Get Nod From FDA But Agency Proceeding With Caution
The FDA has added an at-home self-collection template to its SARS-CoV-2 EUA guidance as more firms seek to develop sampling kits for use in homes.
Androvia LifeSciences has developed a predictive biomarker test that some clinicians are using to determine a man's fertility.